Myriad Genetics | MYGN - Assets



Myriad Genetics reported $1.01B in Assets for its fiscal quarter ending in March of 2025.


Assets Change Date
Agilent USD 12.23B 68M Jul/2025
Becton, Dickinson and Co. USD 54.9B 435M Jun/2025
Bio-Rad Laboratories USD 10.21B 687.2M Jun/2025
Bruker USD 6.34B 406.7M Jun/2025
Danaher USD 81.62B 2.5B Jun/2025
Exact Sciences USD 5.8B 86.29M Jun/2025
Hologic USD 8.81B 261M Jun/2025
Illumina USD 6.09B 95M Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Mettler Toledo International USD 3.4B 165.79M Jun/2025
Myriad Genetics USD 1.01B 21.5M Mar/2025
Quest Diagnostics USD 15.97B 172M Jun/2025
Quidel USD 6.38B 82.5M Jun/2025
Repligen USD 2.85B 22.48M Mar/2025
Revvity USD 12.36B 2.06M Jun/2025
Standard Biotools USD 556.96M 55.38M Jun/2025
Thermo Fisher Scientific USD 101.23B 2.19B Jun/2025
Veracyte USD 1.34B 28.69M Jun/2025
Waters USD 4.72B 126.5M Jun/2025